We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02155647
Previous Study | Return to List | Next Study

Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)

This study is currently recruiting participants.
Verified December 2017 by EMD Serono
Sponsor:
ClinicalTrials.gov Identifier:
NCT02155647
First Posted: June 4, 2014
Last Update Posted: December 15, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
EMD Serono
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 30, 2025
  Estimated Primary Completion Date: September 27, 2019 (Final data collection date for primary outcome measure)